https://www.mdpi.com/2076-393X/9/7/693
The Safety of COVID-19 Vaccinations—We Should Rethink the Policy
*Author to whom correspondence should be addressed.
Academic Editor: Ralph J. DiClemente
Vaccines 2021, 9(7), 693; https://doi.org/10.3390/vaccines9070693
Received: 2 June 2021 / Revised: 19 June 2021 / Accepted: 21 June 2021 / Published: 24 June 2021
(This article belongs to the Section COVID-19 Vaccines and Vaccination)
Abstract
Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and benefits.
Method: We calculated the number needed to vaccinate (NNTV) from a large Israeli field study to prevent one death. We accessed the Adverse Drug Reactions (ADR) database of the European Medicines Agency and of the Dutch National Register (lareb.nl) to extract the number of cases reporting severe side effects and the number of cases with fatal side effects.
Result: The NNTV is between 200–700 to prevent one case of COVID-19 for the mRNA vaccine marketed by Pfizer, while the NNTV to prevent one death is between 9000 and 50,000 (95% confidence interval), with 16,000 as a point estimate. The number of cases experiencing adverse reactions has been reported to be 700 per 100,000 vaccinations. Currently, we see 16 serious side effects per 100,000 vaccinations, and the number of fatal side effects is at 4.11/100,000 vaccinations.
For three deaths prevented by vaccination we have to accept two inflicted by vaccination.
Conclusions: This lack of clear benefit should cause governments to rethink their vaccination policy. View Full-Text
______________________
For more:
- https://madisonarealymesupportgroup.com/2021/05/03/covid-vaccines-necessity-efficacy-and-safety/
- https://madisonarealymesupportgroup.com/2021/06/01/vaccine-researcher-admits-big-mistake-says-spike-protein-is-dangerous-toxin/
- https://madisonarealymesupportgroup.com/2021/05/21/covid-injections-drive-covid-variants-nobel-prize-winner-urges-public-to-reject-jabs/
- https://madisonarealymesupportgroup.com/2021/04/27/covid-19-rna-based-vaccines-the-risk-of-prion-disease/
Regarding efficacy: https://madisonarealymesupportgroup.com/2021/05/06/vaccine-makers-destroy-covid-vaccine-safety-studies/
Excerpt:
- Makers of COVID-19 vaccines are now destroying long-term safety studies by unblinding their trials and giving the control groups the active vaccine, claiming it is “unethical” to withhold an effective vaccine
- In so doing, they make it virtually impossible to assess any long-term safety and effectiveness, and the true benefit versus cost
- It’s ironic, because vaccine mandates are being justified on the premise that the benefit to the community is more important than an individual’s risk of harm.
- Vaccine makers are also very careful about only referencing relative risk, not absolute risk. By doing so, the vaccines appear far more protective than they actually are. It’s a commonly used statistical trick that makes them look more effective than they are.
When absolutely risk is taken into account, the effectiveness of the COVID injections is LESS THAN 1%.
Lastly, a “vaccine” isn’t needed for a disease that has effective treatments; however, these treatments are maligned, censored, and ignored because they want to push their lucrative injections. On top of it all is the fact COVID has the mortality rate of the seasonal flu.
Madison Area Lyme Support Group 